Testing effectiveness (Phase 2)UnknownNCT05036798
What this trial is testing
Tislelizumab+Lenvatinib+Gemox Regiment for Potentially Resectable Locally Advanced Malignant Tumors of Biliary System.
Who this might be right for
Potentially Resectable Locally Advanced Malignant Tumors of Biliary System
Tianjin Medical University Cancer Institute and Hospital 30